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Abstract
The mRNA processing body (P-body) is a cellular structure that regulates the stability of cytoplasmic mRNA. MARF1 is a
murine oocyte RNA-binding protein that is associated with maintenance of mRNA homeostasis and genomic stability. In this
study, autoantibodies were used to identify Limkain B (LMKB), the human orthologue of MARF1, as a P-body component.
Indirect immunofluorescence demonstrated that Ge-1 (a central component of the mammalian core-decapping complex)
co-localized with LMKB in P-bodies. Two-hybrid and co-immunoprecipitation assays were used to demonstrate interaction
between Ge-1 and LMKB. The C-terminal 120 amino acids of LMKB mediated interaction with Ge-1 and the N-terminal 1094
amino acids of Ge-1 were required for interaction with LMKB. LMKB is the first protein identified to date that interacts with
this portion of Ge-1. LMKB was expressed in human B and T lymphocyte cell lines; depletion of LMKB increased expression
of IFI44L, a gene that has been implicated in the cellular response to Type I interferons. The interaction between LMKB/
MARF1, a protein that contains RNA-binding domains, and Ge-1, which interacts with core-decapping proteins, suggests
that LMKB has a role in the regulation of mRNA stability. LMKB appears to have different functions in different cell types:
maintenance of genomic stability in developing oocytes and possible dampening of the inflammatory response in B and T
cells.
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Introduction
Components of the cytoplasmic mRNA processing body (P-
body) have important roles in many aspects of mRNA metabolism.
P-body components participate in the 59-.39 degradation of
mRNA and in microRNA-mediated post-transcriptional gene
silencing (reviewed in [1,2,3,4]). P-body components also have a
role in the transmission of messages in neurons [5,6,7], the cellular
response to viral infections [8,9], the regulation of genomic
stability [10], and in the earliest stages of embryonic development
[11,12]. In view of the contribution of P-bodies to this broad
spectrum of cellular functions, and the relatively limited number of
P-body proteins that have been identified so far, it seems likely that
the full complement of P-body components has not yet been
defined.
Human Limkain B (LMKB, also known as LKAP, KIAA0430)
was originally identified as a protein that interacts with Lim-kinase
1 in a yeast two-hybrid assay (http://www.ncbi.nlm.nih.gov/
nucleotide/18146749). LMKB is a member of a family of proteins
that are predicted to bind RNA. Su and colleagues observed that a
homozygous mutation in the murine orthologue of LMKB,
MARF1 (Meiosis Arrest Female 1), resulted in defective oogenesis
and impaired regulation of retrotransposon activity [13,14].
Approximately 5% of patients with primary biliary cirrhosis
(PBC) produce antibodies directed against P-bodies [15]. PBC is
an autoimmune disease of unknown etiology characterized by
the gradual destruction of intrahepatic, medium-sized biliary
ductules leading to liver failure (reviewed in [16]). The humoral
autoimmune response in PBC patients may begin years, if not
decades, before the onset of overt disease [17]. During this
interval, patients may produce high-titer and high-affinity
antibodies directed against cellular structures, and the antibody
response may spread from one to many proteins in a
macromolecular complex. In previous studies, Eystathioy and
colleagues used autoantibodies to identify P-body component
GW182 [18] and we used PBC sera to identify P-body proteins
Ge-1 (also known as HEDLS and EDC4), RAP55 and YB1
[19,20,21]. In a continuation of these studies, we used patient
serum to screen a proteomic array and identified Limkain B
(LMKB) as a novel P-body component.
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Materials and Methods
Ethics Statement
After written informed consent was obtained, blood samples
were obtained from patients with autoantibodies directed against
mRNA processing bodies. This study was reviewed and approved
by the Partners Health Care Human Institutional Review Board.
Plasmids and Antisera
A cDNA corresponding to the LMKB sequence NM_014647
was ligated into pEGFP (Clontech, Palo Alto, CA) and pDsRFP
(Invitrogen, Carlsbad, CA) to produce plasmids encoding GFP-
LMKB and RFP-LMKB respectively. DNA fragments encoding
LMKB amino acids 1457–1742, 1622–1742, 1–687, 389–1199,
and 1–1642 were prepared using restriction enzymes or oligonu-
cleotides and PCR and the fragments were ligated into pEGFP. A
eukaryotic expression plasmid encoding DCP1 was provided by J.
Lykke-Andersen (University of California, San Diego). A plasmid
encoding full-length Ge-1 fused to GFP and an exogenous nuclear
localization sequence (NLS) corresponding to the SV40 T antigen
NLS (PKKKRKV) was previously reported [22]. Plasmids
encoding GFP-NLS-Ge-1(935–1437), GFP-NLS-Ge-1(630–1437),
GFP-Ge-1(1–1094), GFP-Ge-1(1–935), and GFP-Ge-1(104–1094)
were prepared using restriction enzymes or oligonucleotides and
PCR. The nucleotide sequence of all PCR products was
confirmed. The successful production of each protein fragment
was confirmed by immunoblot.
Serum from a patient with PBC (patient 0081) was identified in
a study to determine the clinical significance of autoantibodies in
PBC [23]. A second human serum (from patient 0121), containing
antibodies directed against Ge-1, was previously described [21].
Serum 0121 did not contain anti-LMKB antibodies, as deter-
mined by immunoblot (not shown) and by lack of reactivity with
LMKB on the protein macroarray. Mouse anti-GFP antibodies
(Invitrogen), rabbit anti-GFP antibodies (Santa Cruz Biotechnol-
ogy), mouse anti-FLAG antibodies (Sigma-Aldrich) and rabbit
anti-RFP antiserum (Clontech) were obtained from the respective
companies. Antibodies directed against LMKB amino acids 1457–
1742 were prepared at Cocalico Biologics, following a standard
protocol. Species-specific secondary antisera, conjugated to FITC,
rhodamine, or coumarin were obtained from Jackson ImmunoR-
esearch Laboratories.
Cell Culture and Immunohistochemistry
Hut78, HL60, HEp-2, and COS-7 cell lines were purchased
from American Type Cell Collection. BJAB and NB4 cell lines
were obtained from E. Kieff (Brigham and Women’s Hospital,
Boston) and M. Lanotte (Inserm U-496, Paris), respectively.
Neuroblastoma cell lines LA1N and LA1S were provided by S.
Cohn (University of Chicago Medical School). Hut78, BJAB, NB4
and HL60 cells were cultured in RPMI; HEp-2, COS-7, LA1N
and LA1S cell lines were maintained in DMEM. RPMI and
DMEM were supplemented with 10% fetal calf serum, L-
glutamine (2 mM), penicillin (200 U/ml) and streptomycin
(200 mg/ml). To induce stress granule formation in Hut78 cells,
the cells were exposed to sodium arsenite (0.5 mM) for 1 hour at
37uC. Prior to immunofluorescent staining, non-adherent
cells (Hut78 and BJAB) were subjected to cytocentrifugation at
500 rpm for 5 minutes. Adherent cells (HEp-2) were grown in
tissue culture chambers (Nunc Inc, Naperville, Ill). Both adherent
and non-adherent cells were subsequently fixed in 4% parafor-
maldehyde in PBS and permeabilized with 100% methanol. Cells
were stained with primary and secondary antisera as previously
described [15]. Slides were examined using a Nikon Eclipse 80i
UV microscope.
Preparation of GST Fusion Protein, SDS-PAGE and
Immunoblotting
Plasmids encoding GST or GST fused to LMKB(1457–1742)
were used to produce recombinant protein in E.coli. Protein
extracts were fractionated in SDS-10% polyacrylamide gels
and transferred to a PVDF membrane. The membrane was
incubated in blocking solution (PBS containing 5% nonfat
milk) for 1 hour at room temperature, followed by human serum
0081 diluted 1:5,000 in blocking solution. Bound human
antibodies were detected using HRP-conjugated goat anti-
human IgG antiserum (Jackson ImmunoResearch) and chemi-
luminescence.
Co-immunoprecipitation Assay
A co-immunoprecipitation assay was used to detect interaction
between carboxyl terminal portions of LMKB and Ge-1. COS-7
cells were transfected with combinations of plasmids encoding
GFP, GFP-LMKB(1457–1742), GFP-LMKB(1622–1742), FLAG-
Ge-1 and FLAG alone (as indicated) using the Neon transfection
system (Life Technologies, Grand Island, NY). Extracts were
prepared from transfected COS-7 cells and incubated with mouse
anti-GFP antibodies and protein G conjugated to Sepharose
beads. Adherent proteins were eluted by boiling in SDS-gel sample
buffer, fractionated by PAGE, and transferred to a PVDF
membrane. Co-precipitated FLAG-Ge-1 was detected using anti-
FLAG antibodies. GFP, GFP-LMKB(1457–1742) and GFP-
LMKB(1622–1742) were detected using rabbit anti-GFP antibod-
ies.
Screening the High-density Protein Macroarray
A high-density protein macroarray prepared from phytohe-
magglutinin-treated human T-cells was obtained from Imagenes
(formerly RZPD). The membrane was rinsed with 100% ethanol
at room temperature and incubated with blocking solution as
previously described [21]. The membrane was incubated over-
night at 4uC with serum 0081 diluted 1:5,000 in blocking solution.
Bound antibodies were detected using HRP-conjugated rabbit
anti-human IgG antiserum (Sigma-Aldridge) and chemilumines-
cence.
Modified Two-hybrid Assay
A previously described modified two-hybrid assay was used to
detect interactions between LMKB and Ge-1 inside HEp-2 cells
[22]. For these studies, plasmids were transfected into HEp-2 cells
using the Effectene transfection system. Cells were fixed and
stained 24 hours after transfection.
Inhibition of LMKB Expression Using Small Interfering
RNA (siRNA)
LMKB mRNA knockdown was achieved using siRNA contained
within lentivirus transduction particles (Sigma-Aldrich catalogue#
TRCN0000061918). A lentivirus containing siRNA directed
against red fluorescent protein was used as a control. SiRNAs
were transduced into BJAB (B lymphocyte) and Hut78 (T
lymphocyte) cell lines as directed by the manufacturer, using a
multiplicity of infection of 10 particles per cell. The levels of LMKB
mRNA and protein in cell lines were assessed using qRT-PCR and
indirect immunofluorescence, respectively.
LMKB Interacts with Ge-1
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Gene Expression
Total RNA was extracted from cell lines using RNeasy
extraction kit (Promega). Complementary DNA was synthesized
using M-MLV reverse transcription (Promega) and LMKB, Line1,
PPP2cb, IFI44L transcript levels were measured by qPCR in a
Mastercycler ep realplex 2 (Eppendorf) using hydrolysis probes
(TaqMan Gene expression assays, Applied Biosystems). Changes
in relative gene expression, normalized to 18S RNA, were
determined using the relative CT method.
Microarray Analysis
Total RNA was extracted from three sets each of LMKB-
depleted, and RFP siRNA-treated (control), BJAB cells. Biotin-
labeled, fragmented cDNA was prepared by the Microarray Core
facility at the Dana Farber Cancer Institute (Boston, MA) and used
to screen Affymetrix GeneChip Human Gene 1.0 ST arrays
(Affymetrix, Santa Clara, CA). Results were analyzed using the
probe logarithmic intensity error (PLIER) method [24]. Values of
signal intensity were log2 transformed and normalized before
Student t test was used to perform probe-specific comparisons.
Genes were considered absent if the group’s average signal
intensity was below the 80th percentile level of negative control
values. Genes with a statistically significant (P,0.05) change of at
least +/21.8 fold were considered differentially expressed [25].
Microarray data are deposited in the Gene Expression Omnibus
(www.ncbi.nlm.nih.gov/geo, dataset GSE55974).
Results
Autoantibodies in the Serum of Patient 0081 React with
Many Known P-body Proteins and with a New P-body
Component, LMKB
Using indirect immunofluorescence and the human HEp-2 cell
line as substrate, we observed that antibodies in serum from PBC
patient 0081 reacted with 5–20 cytoplasmic foci per cell, a
characteristic P-body staining pattern. This serum reacted with
previously identified P-body components Ge-1, RAP55, EDC3
and DCP1 by immunoblot (data not shown). Because serum 0081
reacted with many P-body components, it seemed likely that the
serum might contain antibodies directed against as yet undiscov-
ered P-body proteins. The serum was therefore used to screen a
proteomic array prepared from phytohemagglutinin-treated hu-
man T lymphocytes. In a previous study, six PBC sera were used
to identify 67 immunoreactive proteins in the array [21].
Autoantibodies in serum 0081 reacted with 48 of the previously
reported proteins, as well as eight new proteins: CCDC6, TNFSF,
RASA3, TRIM38, Kri1, EEF2, RBEL1 and KIAA0430 (the last
also known as LMKB). Of these 8 proteins, LMKB was chosen for
further investigation because a previous study suggested that
LMKB is an autoantigen that localizes to a ‘‘subset of
peroxisomes’’ [26], a staining pattern that might appear similar
to the mRNA P-body pattern.
Dunster and colleagues showed that the C-terminus of LMKB
contained at least one of the autoantigen’s immunoreactive
domains [26]. To confirm that LMKB was a target of antibodies
in serum 0081, the serum was incubated with an immunoblot
prepared using GST fused to the carboxyl terminus of LMKB
(amino acids 1457–1742). Serum 0081 contained antibodies
directed against this portion of the protein (Figure 1).
To further investigate the cellular location of LMKB, a plasmid
encoding full-length LMKB fused to green fluorescent protein
(GFP) was prepared and co-expressed with FLAG-Ge-1 in HEp-2
cells. The two proteins co-localized in cytoplasmic dots (Figure 2,
i–iii). Co-expression of GFP-LMKB and FLAG-DCP1 in HEp-2
cells also resulted in co-localization of the two proteins in
cytoplasmic dots (Figure S1, i–iii). These results confirm that
LMKB is a component of mRNA P-bodies.
The Structure of LMKB and Expression of LMKB in Human
Cell Lines
LMKB is a member of a family of proteins that contains motifs
found in Oskar and vertebrate Tudor (‘‘OST’’) proteins [27].
These motifs are predicted to adopt a winged helix-turn-helix
(‘‘HTH’’) fold that is capable of binding double-stranded RNA.
LMKB contains eight C-terminal OST motifs between amino
acids 879–1557 (http://www.ncbi.nlm.nih.gov/Structure/cdd/
wrpsb.cgi?SEQUENCE=124487213&FULL, [28]). LMKB has
two additional RNA recognition motif (RRM)-type RNA binding
domains, between amino acids 510–600 and 792–867. The N-
terminus of LMKB (amino acids 351–493) contains a predicted
globular structure that may serve as a cation binding domain (http://
www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=
10&seltype=2&uid=199896).
Rabbit anti-LMKB antibodies were used to probe the
expression of LMKB in a panel of human cell lines. Because we
originally identified LMKB in a protein array derived from T
lymphocytes, we stained the human helper T cell line Hut78 for
the protein. In these cells, LMKB localized to cytoplasmic dots
and co-localized with endogenous Ge-1 (Figure 2, iv-vi). LMKB
was also detected in P-bodies in the human B cell line BJAB (not
shown). LMKB was not detected by indirect immunofluorescence
in EBV-transformed B cells lines, in myeloid cell lines HL60 and
NB4, in neuroblastoma cell lines LA1N and LA1S, or in HEp-2
cells.
To examine the effect of stress on the cellular distribution of
LMKB, Hut78 cells were treated with arsenite for 1 hour and
then zstained with antibodies directed against LMKB and the
stress granule marker TIA. LMKB-containing P-bodies localized
Figure 1. Antibodies in the serum of patient 0081 react with
LMKB. The human serum contained antibodies directed against GST-
LMKB amino acids 1457–1742, but did not react with GST alone. Black
arrow indicates location of the GST-LMKB fusion protein.
doi:10.1371/journal.pone.0094784.g001
LMKB Interacts with Ge-1
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adjacent to stress granules, but LMKB was not detected within
stress granules (Figure 2, vii-ix). LMKB is therefore similar to Ge-1
in that it does not localize to stress granules [29]. In contrast, other
P-body components, such as RAP55, RCK, Eif4E, Xrn1 and YB-
1 were previously found to localize to stress granules in response to
arsenite treatment [20,30,31].
LMKB Interacts with Ge-1
Because LMKB co-localized with Ge-1 in P-bodies and had a
similar cellular distribution after exposure to arsenite, we tested the
possibility that LMKB interacts with Ge-1. The large size of both
Ge-1 and LMKB, and the relative instability of full-length LMKB,
made it technically difficult to demonstrate interaction using co-
immunoprecipitation. We therefore used a modified two-hybrid
assay to test for interaction between the two proteins inside cells.
As previously described [22], this assay takes advantage of the
observation that Ge-1, when fused to an exogenous nuclear
localization sequence (NLS) and expressed in HEp-2 cells, localizes
to nuclear dots. Co-expression of NLS-Ge-1 with proteins that
interact with Ge-1, including DCP1, DCP2 or Ge-1 itself, resulted
in localization of both proteins to these nuclear structures. In
contrast, proteins that do not interact with Ge-1, including RCK,
EDC3 and RAP55, did not co-localize with NLS-Ge-1 [22]. After
co-expression of NLS-Ge-1 and GFP-LMKB in HEp-2 cells, both
NLS-Ge-1 and GFP-LMKB were detected in nuclear dots
(Figure 3A, i–iii). When expressed without NLS-Ge-1, GFP-
LMKB localized to the cytoplasm (see Figure 2i). The results
suggest that LMKB and Ge-1 are able to interact within HEp-2
cells.
To identify the portion of LMKB that mediates interaction with
Ge-1, fragments of LMKB fused to GFP were co-expressed with
NLS-Ge-1 in HEp-2 cells. LMKB fragments containing the C-
terminal portion of the protein, including amino acids 1457–1742
(not shown) and 1622–1742 (Figure 3A, iv–vi), were sufficient to
mediate co-localization with NLS-Ge-1 in nuclear dots. N-
terminal portions of LMKB, including fragments containing
amino acids 1–687, 389–1199 (both not shown), and 1–1622
(Figure 3A, vii–ix) did not co-localize with NLS-Ge-1. The LMKB
fragment containing amino acids 1622–1742 was the smallest
portion of LMKB tested that was capable of interacting with Ge-1.
The results are summarized in Figure 3B.
To confirm that the C-terminal portion of LMKB was sufficient
to mediate interaction with Ge-1, plasmids encoding GFP-
LMKB(1457–1742), GFP-LMKB(1622–1742) or GFP alone were
co-transfected with FLAG-Ge-1 into COS-7 cells. Mouse anti-
GFP was able to co-precipitate FLAG-Ge-1 in extracts prepared
from cells expressing GFP-LMKB(1457–1742) and FLAG-Ge-1,
Figure 2. Indirect immunofluorescence shows that LMKB localizes to P-bodies. GFP-LMKB (green, i) localized to discrete, dot-like structures
in the cytoplasm of transfected HEp-2 cells and co-localized with co-expressed FLAG-Ge-1 (red, ii). To determine the cellular location of endogenous
LMKB, rabbit anti-LMKB antiserum was used to stain Hut78 cells. LMKB (green, iv) co-localized with Ge-1 (red, v), identified using human serum 0121.
After exposure to arsenite for 1 hour, TIA (a marker of stress granules) was detected in cytoplasmic granules (red, viii). LMKB (green, vii) did not co-
localize with TIA in stress granules, but was instead detected in adjacent P-bodies. Merge of fluorescence in i and ii, iv and v, vii and viii is shown in iii,
vi and ix. DAPI staining in iii and vi (blue) indicates the location of nuclei. White arrows in vii and ix indicate representative LMKB-containing P-bodies
adjacent to stress granules. White bar in ix indicates 5.0 mm.
doi:10.1371/journal.pone.0094784.g002
LMKB Interacts with Ge-1
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and GFP-LMKB(1622–1742) and FLAG-Ge-1, but not from cells
expression GFP and FLAG-Ge-1 (Figure 4).
To identify the portion of Ge-1 that mediates interaction with
LMKB, plasmids encoding fragments of Ge-1 fused to GFP and
NLS were co-expressed with a plasmid encoding red fluorescent
protein (RFP) fused to LMKB. Previous studies showed that the
carboxyl portion of Ge-1 was sufficient to mediate interaction with
DCP1, DCP2, and Ge-1 itself [22]. However, GFP-NLS-Ge-1
fusion proteins containing amino acids 935–1437 (not shown) or
630–1437 (Figure 5A, i–iii) did not recruit RFP-LMKB into the
nucleus, suggesting that motifs in the N-terminal portion of Ge-1
are required for interaction between the two proteins. Unfortu-
nately, even when fused to an exogenous NLS, the N-terminal
portion of Ge-1 did not localize to the nucleus (data not shown). In
addition, as previously reported [29], the N-terminal portion of.
Ge-1 did not localize to P-bodies. Therefore, to identify the N-
terminal portion of Ge-1 that interacts with LMKB, the two-
hybrid assay was further modified so as to test for the ability of
RFP-LMKB to mediate localization of N-terminal Ge-1 fragments
to P-bodies. Co-expression of RFP-LMKB and GFP-Ge-1(1–1094)
resulted in both proteins localizing to cytoplasmic dots (Figure 5A,
iv–vi). RFP-LMKB and GFP-Ge-1(1–1094) co-localized with
endogenous Ge-1, identified using human serum containing anti-
Ge-1 antibodies, suggesting that the cytoplasmic dots containing
Figure 3. A. A modified two-hybrid assay was used to test for
interaction between LMKB and Ge-1 and to identify the
portion of LMKB that mediates interaction with Ge-1. Expression
of a plasmid encoding Ge-1 fused to a nuclear localization sequence
(NLS) shifted some of the protein from the cytoplasm to the nucleus of
HEp-2 cells (red, i, iv and vii), where it localized to dot-like structures.
Co-transfection of plasmids encoding GFP fused to full-length LMKB
(green, ii) and NLS-Ge-1 resulted in co-localization of the two proteins in
nuclear dots. GFP-LMKB fragment fusion proteins encoding amino acids
1622–1742 (green, v) also co-localized with co-expressed NLS-Ge-1 (red,
iv) in nuclear dots. GFP-LMKB fragments encoding 1–687 and 389–1199
(both not shown) and 1–1622 (green, viii) did not co-localize with NLS-
Ge-1 in nuclear dots. Merge of fluorescence in i and ii, iv and v, vii and
viii is shown in iii, vi and ix. DAPI staining (blue) in iii, vi and ix indicates
the location of nuclei. Human serum 0121 containing anti-Ge-1
antibodies and mouse monoclonal anti-GFP antibodies were used to
detect Ge-1 and GFP, respectively. White arrows in vii and ix indicate
nuclear dots containing NLS-Ge-1. White bar in ix indicates 5.0 mm. B.
Schematic representation of the structure of LMKB and summary of
results. LMKB contains an N-terminal globular domain (‘‘LK’’, amino
acids 351–493) that may serve as a cation binding domain. Two RRM-
type RNA binding domains are located between amino acids 510–600
and 792–867. The C-terminus of LMKB contains eight helix-turn-helix
folds (‘‘OST domains’’) that are predicted to bind to dsRNA (amino acids
879–937, 1004–1074, 1100–1170, 1176–1247, 1259–1330, 1337–1406,
1412–1484, 1487–1557; numbering system is as indicated in GenBank
#NM_014647). + indicates an interaction between a LMKB fragment
and Ge-1; - indicates a fragment of LMKB that does not interact with Ge-
1. The black rectangle indicates the smallest tested portion of LMKB
that interacts with Ge-1.
doi:10.1371/journal.pone.0094784.g003
Figure 4. Ge-1 co-precipitates with C-terminal fragments of
LMKB. COS-7 cells were transfected with plasmids encoding FLAG-Ge-
1, GFP-LMKBc (containing amino acids 1457–1742), GFP-LMKBc’ (amino
acids 1622–1742), FLAG and GFP as indicated. Extracts were prepared
and incubated with mouse anti-GFP antibody and protein G coupled to
Sepharose beads. Precipitates (top two panels) are compared with 5%
of the total COS-7 cell extract input (bottom two panels). FLAG-Ge-1 co-
precipitated with GFP-LMKBc(1457–1742) and with GFP-LMKBc’(1622–
1742), but not with GFP alone.
doi:10.1371/journal.pone.0094784.g004
LMKB Interacts with Ge-1
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RFP-LMKB and GFP-Ge-1(1–1094) are P-bodies (Figure 5A, vii–
ix). It seems likely that LMKB is able to bind more than one Ge-1
molecule and is thereby able to recruit GFP-Ge-1(1–1094) to
endogenous Ge-1 in P-bodies. In cells transfected with plasmids
encoding RFP (not fused to LMKB) and GFP-Ge-1(1–1094), GFP-
Ge-1(1–1094) failed to localize to cytoplasmic dots, but was instead
distributed throughout the cytoplasm (Figure 5A, x–xii). GFP-Ge-
1 fragments lacking an additional 159 amino acids from the
Figure 5. A. Delineation of the smallest portion of Ge-1 that mediates interaction with LMKB. GFP-NLS-Ge-1 fragment (amino acids 630–
1437) localized to nuclear dots (green, ii) in HEp-2 cells, but RFP-LMKB remained in P-bodies and was not detected in the nucleus (red, i), suggesting
that N-terminal amino acids in Ge-1 are required for interaction with LMKB. To identify the N-terminal portion of Ge-1 that interacts with LMKB, RFP-
LMKB was tested for the ability to recruit N-terminal fragments of Ge-1 to P-bodies. In the presence of RFP-LMKB (red, iv), GFP-Ge-1(1–1094) localized
to cytoplasmic dots resembling P-bodies (green, v). In cells expressing RFP-LMKB (red, vii) and GFP-Ge-1(1–1094) (green, viii), both proteins co-
localized with endogenous Ge-1 (blue, ix), confirming that these structures are P-bodies. In the absence of LMKB (RFP alone, red, x), GFP-Ge-1(1–1094)
did not localize to P-bodies (green, xi), but was instead distributed throughout the cytoplasm. Smaller fragments of Ge-1, including amino acids 1–
935 (green, xiv) and 104–1094 (green, xvii) did not co-localize with co-expressed LMKB in P-bodies. Merge of fluorescence in i and ii, iv and v, x and xi,
xiii and xiv, and xvi and xvii is shown in iii, vi, xii, xv and xviii. DAPI staining (blue in the merged panels) indicates the location of nuclei. White bar in
xviii indicates 5.0 mm. B. Schematic representation of Ge-1 and summary of results. The N-terminus of Ge-1 contains a WD40 repeat domain. The C-
terminus contains four regions that have repeating hydrophobic residue periodicity (y(X2-3)-repeat domains). + indicates a fragment of Ge-1 that
interacts with LMKB; - indicates a fragment of Ge-1 that does not interact with LMKB. The black rectangle indicates the smallest tested portion of Ge-1
that interacts with LMKB.
doi:10.1371/journal.pone.0094784.g005
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C-terminus, or 104 amino acids from the N-terminus, of Ge-1 did
not co-localize with RFP-LMKB in P-bodies (Figure 5A, xiii–xviii).
These results, which are summarized in Figure 5B, suggest that
Ge-1 amino acids 1–1094 contain the portion of the protein that
mediates interaction with LMKB.
The Effects of LMKB Depletion in BJAB and Hut78 Cell
Lines
Su and colleagues showed that mutations in MARF1 resulted in
upregulation of a cohort of transcripts, including Line1 retro-
transposon- and PPP2cb- mRNA [13]. To investigate whether
depletion of LMKB in human T and B cell lines produced similar
effects, we used siRNA to decrease LMKB mRNA and protein and
measured Line1 and PPP2cb mRNA levels. BJAB and Hut78 cells
were treated with lentivirus particles containing LMKB or control
siRNA. LMKB siRNA produced a greater than 80% decrease in
LMKB mRNA levels in both BJAB and Hut78 cell lines (Figure 6,
i). Immunoblot confirmed that the level of LMKB protein was
markedly reduced in LMKB-depleted BJAB cells, compared with
controls (Figure S2). In addition, after knockdown, LMKB was no
longer detected by indirect immunofluorescence in either BJAB
(Figure 7, i–vi) or Hut78 (Figure 7, vii) cells. Depletion of LMKB
had no effect on staining for Ge-1 (Figure 7, vii-xii), suggesting that
LMKB is not required for P-body integrity.
Line1 mRNA was not detected by qRT-PCR in BJAB or Hut78
cells either before or after LMKB depletion. In addition, the level
of PPP2cb mRNA was not affected by LMKB depletion in either
cell line (Figure 6, ii). To further investigate the potential function
of LMKB in human lymphocytes, we compared the LMKB-
depleted BJAB transcriptome with that of control BJAB cells.
Twelve genes, including LMKB itself, were down-regulated more
than 1.8-fold. The mRNA levels of 15 genes were up-regulated
more than 1.8-fold (Table 1). In BJAB cells, the microarray results
indicated that there was a greater than five-fold increase in IFI44L
mRNA, an increase that was confirmed using qRT-PCR (Figure 6,
iii). An even greater increase in IFI44L mRNA was detected in
LMKB-depleted Hut78 cells compared with control cells (LMKB
knockdown vs control, 18 vs 1.0, p,.001). The mRNA level of
other interferon inducible genes, such as Mx-1, was not altered by
LMKB depletion.
Discussion
In this study, we used serum from a patient with autoantibodies
directed against mRNA P-bodies to identify LMKB as a potential
Figure 6. The effects of LMKB depletion on gene expression in BJAB and Hut78 cells. SiRNA-mediated knock-down of LMKB in BJAB and
Hut78 cells resulted in a greater than 80% decrease in the level of LMKB mRNA (i). LMKB depletion had no effect on the level of PPP2cb mRNA in
either cell line (ii). The level of IFI44L mRNA was increased in both BJAB and Hut78 cell lines after LMKB knock-down (iii).
doi:10.1371/journal.pone.0094784.g006
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component of these structures. When expressed in HEp-2 cells
together with FLAG-Ge-1, GFP-LMKB and FLAG-Ge-1 co-
localized in P-bodies. Endogenous LMKB also localized to P-
bodies, confirming that LMKB is a new P-body component.
Depletion of LMKB in Hut78 cells did not alter the cellular
distribution of Ge-1, suggesting that the presence of LMKB is not
required for the integrity of P-bodies.
Interaction between LMKB and Ge-1
A modified two-hybrid assay was used to test for interaction
between LMKB and Ge-1. When GFP-LMKB was expressed in
HEp-2 cells with Ge-1 fused to an exogenous NLS, both proteins
localized to nuclear dots. When expressed in HEp-2 cells without
NLS-Ge-1, GFP-LMKB localized in the cytoplasm. These results
suggest that LMKB and Ge-1 interact inside the cell.
Expression of plasmids encoding fragments of LMKB together
with NLS-Ge-1 revealed that the C-terminus of LMKB (amino
acids 1622–1742) was the smallest portion of the protein capable
of mediating interaction with Ge-1. The results of the two-hybrid
assay were confirmed by studies, which showed that C-terminal
portions of LMKB were able to co-precipitate FLAG-Ge-1 from
COS-7 cell extracts.
To identify the portion of Ge-1 that mediates interaction
with LMKB, plasmids encoding fragments of Ge-1 were co-
expressed with full-length LMKB. Portions of Ge-1 that lack the
C-terminus of Ge-1 (amino acids 935–1437) were unable to
Figure 7. Loss of LMKB immunoreactivity after LMKB knockdown in BJAB and Hut78 cells. Treatment of BJAB cells with siRNA directed
against LMKB resulted in loss of P-body staining as determined by indirect immunofluorescence (i). LMKB was detected in a cytoplasmic dot staining
pattern in cells treated with control siRNA (green, iv). DAPI staining (blue) in ii and v indicate the location of nuclei. Merge of the preceding panels is
shown in iii and vi. Treatment of Hut78 cells with siRNA directed against LMKB also resulted in loss of cytoplasmic dot staining (vii), compared with
cells treated with control siRNA (green, x). Loss of LMKB did not alter the cellular location of Ge-1-containing P-bodies (red, viii and xi) demonstrating
that LMKB is not required for P-body formation. Merge of vii and viii, and x and xi, is shown in ix and xii. DAPI staining (blue) in the merged panels
indicates the location of nuclei. White bar in xii indicates 5.0 mm.
doi:10.1371/journal.pone.0094784.g007
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localize to P-bodies. However, when co-expressed with LMKB,
Ge-1(1–1094) co-localized with LMKB in P-bodies. LMKB is the
first protein identified to date that interacts with this portion of
Ge-1.
The Role of LMKB in Lymphocyte Cell Lines
Su and colleagues observed that homozygous mutation in
LMKB, the murine orthologue of MARF1, resulted in defective
oogenesis and impaired regulation of retrotransposon activity
[13,14]. Analysis of the MARF1 mutant oocyte transcriptome
using microarrays revealed 377 transcripts that were increased and
27 decreased compared with wild-type oocytes. There was a
marked up-regulation of PPP2cb mRNA, encoding the beta-
isoform catalytic subunit of PP2A. Increased levels of PPP2cb may
contribute to the observed meiotic arrest and infertility observed in
Marf12/2 mice. Mutation in MARF1 also increased the level of
retrotransposon Line1 mRNA in developing oocytes. Because
retrotransposons may alter genomic stability by randomly
inserting into the genome and inducing double-stranded DNA
breaks, Su and colleagues concluded that murine LMKB might
have a role in the maintenance of genomic integrity of developing
oocytes [14].
In this study, we observed that LMKB was expressed in human
T and B cell lines. Depletion of LMKB in BJAB and Hut78 cells
did not produce the same effects as seen in LMKB-deficient
oocytes. Line1 retrotransposon mRNA was not detected in either
control or LMKB-depleted cell lines. LMKB depletion also had no
effect on the level of PPP2cb mRNA in lymphocyte cell lines. In
contrast, depletion of LMKB in both Hut78 and BJAB cells
increased the level of IFI44L mRNA. Although the function of
IFI44L is unknown, increased IFI44L gene expression is a
component of the Type 1 interferon response signature [32].
Increased levels of IFI44L mRNA are also part of the cellular
response to viral infection [33]. The observation that LMKB may
regulate the mRNA level of IFI44L, but not other components of
the Type I interferon response signature, suggests that LMKB may
have a specific, and perhaps subtle, role in limiting the
inflammatory response.
In summary, in this study we identified LMKB, a putative RNA
binding protein, as a component of mammalian mRNA P-bodies.
The C-terminus of LMKB mediated interaction with Ge-1, while
the N-terminus of Ge-1 was required for interaction with LMKB.
Depletion of LMKB in T and B cell lines resulted in increased
expression of IFI44L, a component of the Type I interferon
Table 1. List of genes differentially expressed in BJAB cells after LMKB knockdown compared with control BJAB cells.
Gene Affymetrix Gene ID Fold Change P-value
Upregulated
IFI44L 7902541 5.34 1.91E-04
NCAM2 8067985 3.03 3.73E-03
AFF2 8170364 2.70 9.21E-03
HIST1H4D 8124413 2.36 1.43E-03
TTTY10 8177261 2.04 4.09E-02
LILRB1 8031223 1.96 6.69E-03
HIST1H2BM 8117594 1.96 4.46E-02
MME 8083494 1.92 3.34E-03
C6orf25 8178074 1.90 1.17E-02
MGC24125 8103906 1.88 8.72E-04
OLR1 7961142 1.86 1.04E-02
TUBA3E 8055194 1.85 1.38E-02
BACE2 8068671 1.82 6.31E-04
CHRNA6 8150550 1.81 6.88E-03
CXCL13 8095886 1.81 1.76E-02
Downregulated
SPATS2L 8047272 21.80 4.97E-04
JAG1 8064978 21.81 1.96E-05
MKKS 8064967 21.86 1.13E-04
DRP2 8168817 21.89 7.07E-03
FGFR1OP2 7954492 21.89 6.19E-05
ESF1 8065032 21.94 2.51E-04
CRYBG3 8081171 21.96 9.36E-03
PPP1R2P1 8125527 22.07 3.65E-02
LOC644714 8161943 22.07 4.07E-02
KIAA0430 (LMKB) 7999642 22.26 1.99E-04
ANAPC13 8090866 22.27 1.16E-05
MYBPC1 7957966 23.03 1.45E-03
doi:10.1371/journal.pone.0094784.t001
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response signature. In the absence of LMKB, IFI44L mRNA may
fail to be recruited to mRNA P-bodies and may therefore retain a
59cap and be resistant to 59 -.39 exoribonuclease-mediated
degradation.
Supporting Information
Figure S1 LMKB co-localizes with DCP1 in mRNA
processing bodies. GFP-LMKB (green, i) localized to discrete,
dot-like structures in the cytoplasm of transfected HEp-2 cells and
co-localized with co-expressed FLAG-DCP1 (red, ii). Merge of
fluorescence in i and ii is shown in iii. DAPI staining in iii (blue)
indicates location of nuclei. White bar in iii indicates 5.0 mm.
(TIFF)
Figure S2 LMKB knock-down decreased the level of
immunoreactive LMKB in BJAB cells. Immunoblot was used
to further confirm that si-RNA-mediated knockdown decreased
the level of LMKB protein in BJAB cells. Because of the relatively
low level of LMKB in wild-type BJAB cells, human serum
containing anti-LMKB antibodies was used to immunoprecipitate
LMKB from BJAB cells prior to immunoblot. Precipitates were
fractionated by SDS-PAGE, transferred to PVDF membranes and
incubated with rabbit anti-LMKB antiserum. The level of LMKB
was markedly reduced in LMKB-depleted (lane 3) compared with
control (lane 1) BJAB cells. LMKB was not detected in either cell
line when normal human serum (NHS) was used to immunopre-
cipitate LMKB (lanes 2 and 4).
(TIFF)
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